التفاصيل البيبلوغرافية
| العنوان: |
Possible risk of interstitial lung diseases in myelodysplastic syndrome patients with chromosome der(1;7)(q10;p10) and/or +8 during azacitidine therapy. |
| المؤلفون: |
Tabata, Rie1 (AUTHOR) rie.tabata@noe.saiseikai.or.jp, Tabata, Chiharu2 (AUTHOR) |
| المصدر: |
British Journal of Haematology. Apr2024, Vol. 204 Issue 4, p1557-1560. 4p. |
| مصطلحات موضوعية: |
*IDIOPATHIC interstitial pneumonias, *INTERSTITIAL lung diseases, *MYELODYSPLASTIC syndromes, *AZACITIDINE, *CHROMOSOMES, *ACUTE myeloid leukemia |
| مستخلص: |
This article discusses a study that examined the risk of interstitial lung diseases (ILDs) in patients with myelodysplastic syndrome (MDS) undergoing azacitidine therapy. The study found suggestive findings for ILD in three patients out of 73 with MDS or acute myeloid leukaemia (AML) with myelodysplasia-related changes (MRCs). These patients were diagnosed with ILD based on tests and examinations. The study suggests that patients with MDS and specific chromosomal abnormalities may be at a higher risk of developing ILD during azacitidine therapy, but further research is needed to confirm these findings. Clinicians should exercise caution when considering azacitidine therapy for these patients. [Extracted from the article] |
| قاعدة البيانات: |
Academic Search Index |